KISIMA-01
Showing 26 - 50 of 879
Fatigue Trial in Nerul, Jaipur (E-OJ-01, Microcrystalline cellulose)
Not yet recruiting
- Fatigue
- E-OJ-01
- Microcrystalline cellulose
-
Nerul, Maharashtra, India
- +1 more
Nov 22, 2022
Endometrial Cancer Trial in Houston (DKN-01, Pembrolizumab)
Not yet recruiting
- Endometrial Cancer
-
Houston, TexasM D Anderson Cancer Center
Feb 27, 2023
Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)
Recruiting
- Pulmonary Tuberculosis
- Other Specified Pulmonary Tuberculosis
- Sutezolid
- +6 more
-
Lambaréné, Gabon
- +7 more
Apr 17, 2023
Healthcare Resource Utilization and Costs in Metastatic Melanoma
Terminated
- Metastatic Melanoma
-
East Hanover, New JerseyNovartis Investigational Site
Apr 27, 2023
Transfusion Dependent Beta-Thalassaemia Trial in Nanning (ET-01)
Recruiting
- Transfusion Dependent Beta-Thalassaemia
- ET-01
-
Nanning, Guangxi, ChinaPLA 923 Hospital
Mar 2, 2023
Solid Tumor Trial in Kunming (RD14-01)
Recruiting
- Solid Tumor
- RD14-01
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Feb 18, 2023
Advanced Solid Tumor Trial in Nijmegen (PRECIOUS-01)
Recruiting
- Advanced Solid Tumor
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Oct 26, 2022
Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Lymphoma Trial in Hangzhou (RD14-01 cell infusion)
Recruiting
- Mantle Cell Lymphoma
- +2 more
- RD14-01 cell infusion
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, College of Medicine, Zhejiang Uni
Jul 6, 2022
NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting
Not yet recruiting
- Non-small Cell Lung Cancer
- +5 more
- Autologous, engineered T Cells targeting TP53 R175H
-
Duarte, CaliforniaCity of Hope
May 17, 2023
Advanced Solid Tumor, Relapsed AML, Refractory AML Trial in Hong Kong (NEI-01)
Recruiting
- Advanced Solid Tumor
- +2 more
-
Hong Kong, Hong KongThe University of Hong Kong Phase I Clinical Trials Centre
May 6, 2022
Resected Stage II or Stage III Colorectal Cancer for Circulating
Recruiting
- Colorectal Cancer Stage II
- Colorectal Cancer Stage III
- Regular blood sample collection for ctDNA assessment
-
California City, California
- +66 more
Jan 6, 2023
Healthy Volunteers Trial in Shanghai (JS1-1-01, Placebo)
Recruiting
- Healthy Volunteers
- JS1-1-01
- Placebo
-
Shanghai, ChinaShanghai Mental Health Center
Dec 16, 2022
Metastatic Lung Non-Small Cell Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Orange,
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +8 more
-
Orange, California
- +2 more
Aug 10, 2022
CEA mRNA in Smog and Tissue Exudate Whole Process Collected
Recruiting
- Gastric Cancer
- Radical Gastric Cancer Surgery
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
Oct 7, 2023
Pancreatic Adenocarcinoma, Metastatic Trial in Spain, United States (Nab-paclitaxel, Gemcitabine, VCN-01)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Metastatic
- Nab-paclitaxel
- +2 more
-
New York, New York
- +7 more
Jan 3, 2023
Diabetic Macular Edema Trial in Beverly Hills (Active treatment arm: OCS-01 (dexamethasone), Vehicle)
Active, not recruiting
- Diabetic Macular Edema
- Active treatment arm: OCS-01 (dexamethasone)
- Vehicle
-
Beverly Hills, CaliforniaOculis Investigative Site
Jan 13, 2023
Cerebral Adrenoleukodystrophy Trial in Minneapolis (Mesenchymal stem cells (IV-MSC))
Recruiting
- Cerebral Adrenoleukodystrophy
- Mesenchymal stem cells (IV-MSC)
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Sep 7, 2023
COVID19 Trial in Guangzhou (Recombinant SARS-CoV-2 Fusion Protein Vaccine)
Completed
- COVID19
- Recombinant SARS-CoV-2 Fusion Protein Vaccine
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Center for Disease Control and Prevention
Feb 10, 2022
Healthy Trial (VER-01)
Completed
- Healthy
-
Vienna, AustriaUniversity of Medicine in Vienna - Department of Clinical Pharma
Nov 24, 2022
A Long-term, 3-Year, Follow-up Study for Patients Completing
Enrolling by invitation
- Lumbosacral Radiculopathy
-
Salt Lake City, UtahKolon Investigative Site : CenExel JBR
Nov 6, 2022
Unresectable Melanoma, Metastatic Melanoma Trial in Brussel, Amsterdam, Barcelona (NEO-PTC-01)
Recruiting
- Unresectable Melanoma
- Metastatic Melanoma
- NEO-PTC-01
-
Brussel, Belgium
- +2 more
Dec 5, 2022
Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL Trial in Spain (blinatumomab)
Terminated
- Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
-
Badalona, Barcelona, Spain
- +11 more
Jul 26, 2022